That's right: I reference using APA6. In blogs. I'm cool.
Anyway, Sue Dunlevy (the author) has copped a bit of flak over the article from the Guild and pharmacists who've alleged she's misrepresented the profession and brought it into disrepute. The Guild have called the article "plain wrong", while others have noted the author seems to be involved with every bad pharmacy news story published by News Corp Australia. To be fair, she is a health reporter; if there's anyone at News Corp Australia who's going to report on a health-related issue, it'd be her, which is why her name comes up frequently.
Look, I think there's a couple of things she could've done to improve the article. For instance, it would've been nice if the article clearly stated the $4.11 'allowable additional patient charge' was also capped by the general patient co-payment, or that it couldn't be applied to concession patients (Commonwealth of Australia, n.d.). It would've been more realistic if she gave the average percent over market price the Government pays rather than the 80 percent (though I wouldn't know what that average is). Probably the most important thing missing is evidence of whether pharmacies are actually applying this charge and if so, how many, where and to what medicines.
Having said all that though, I've read the thing maybe half a dozen times now, and while I initially got that feeling she was trashing the reputation of the profession, I don't see it now and I think I was wrong when I reacted to the article that way initially.
Excusing the points I made above, everything else in that article seems legitimate. Yes, there is an allowable additional patient charge, capped at $4.11 that can be applied at the pharmacy's discretion to medicines priced beneath the general co-payment. If charged, it doesn't count towards the patient's Safety Net threshold. Yes, it could be used to offset or 'top up' the cost of a medicine if it falls beneath $36.10 and yes, there's plenty of evidence to show that the cost of a medication can affect patient adherence (Ortiz, 2013). Given that evidence, it's unsurprising that Rollo Manning, CHF chief Carol Bennett and Professor Phillip Clarke express concern. The Guild weren't robbed of right of reply; the article gives a Guild spokesperson the opportunity to ground this patient charge in the everyday reality of community pharmacy.
I think the response I'm seeing to this article from pharmacists says more about the frustration they feel, considering many in the professional are genuinely doing the best they can to improve patient outcomes. Community pharmacy is stuck between the figurative rock and a hard place on this, because pharmacists know and see patients holding off from getting scripts filled for cost reasons, but in order to provide a professional service, pharmacies have to remain financially viable.
This is the argument that needs to be presented to the community; that it isn't just about cost to the consumer, and that compromising pharmacy financially can have far-reaching effects on health outcomes, beyond affordability. The recent actions by the Guild and releases from the PSA and NAPSA have taken the right approach on this I think with respect to the price disclosure issue.
Of course, it could also be the timing of the article (right in the middle of the campaign against the advancement of price disclosure), which is unfortunate. Still, she wrote it and it's released now, so if pharmacy is going to have a discussion with the community about this $4.11 charge, we should be talking about why it's in there, why pharmacies have it to use at their discretion (even if they aren't using it). and what we can all do about finding a way to work around having to use it or need it in future.
This is where I can't trust the Guild; I think they have it totally wrong in their reply by media release (Pharmacy Guild of Australia, 2013), by 'straw manning' her argument, suggesting she was saying pharmacies can use the charge above the general co-payment, which she never said. Furthermore they focus on the 'secret' part and forget the part where she says 'chemists are required to tell patients when they impose the $4.11 charge and the fact it is not initiated by the government'. Most frustrating of all, the media release doesn't attempt to grapple at all with the truths in the article, calling it 'plain wrong'. I tried querying the Guild on this via their Facebook page, and the reply I got again falsely accused the article of saying the charge could be used above the co-payment. I'll quote directly from the article: "...chemists can top up the cost of medicines that fall below a $36.10 co-payment figure...". That's "above", not "below". The two words don't even look similar.
Hmph. It seems to me if they're going to accuse someone of being 'deliberately misleading', they could probably do with a look in the mirror.
Am I wrong? Do I think too highly of the comprehension skills of the Guild's media team? I mean, how likely do you think it is they responded to the article in that way because it was misread? I don't think that's likely, and as a result I can't help but think the media release is a deliberate attempt to obfuscate the issue, either generating sympathy for pharmacy or stirring the pot to energise the base for the 'Under Threat' campaign.
Feel free to correct me if I've got facts wrong or made an error in interpretation, or used poor assumptions.
References (though I wonder what's the point where I learnt to hyperlink text through the article) (Is it cheating to reference paper journals like Australian Prescriber more simply by referencing them as websites where applicable?)
Commonwealth of Australia. (n.d.) Fees, Patient Contributions and Safety Net Thresholds - History of PBS Copayments and Safety Net Thresholds. Retrieved 16/08/2013, from http://www.pbs.gov.au/info/healthpro/explanatory-notes/front/fee
Dunlevy, S. (2013). Patients miss out on prescription medicines price cut. Retrieved 16/08/2013, from http://www.news.com.au/lifestyle/health-fitness/patients-miss-out-on-prescription-medicines-price-cut/story-fneuz9ev-1226696601576
Ortiz, M. (2013). Are prescription copayments compromising patient care? Retrieved 16/08/2013, from http://www.australianprescriber.com/magazine/36/1/2/3
The Pharmacy Guild of Australia. (2013). Media Release - Media reports on medicine pricing just plain wrong. Retrieved 16/08/13, from http://www.guild.org.au/news-page/2013/08/14/media-release---media-reports-on-medicine-pricing-just-plain-wrong
Followup: This is incidentally related, but a recent review article in PLoS Medicine demonstrated how medication adherence varies with amount paid by patient for antihypertensives.
ReplyDeleteIt's important to keep in context than none of the articles used for the review studied the Australian context, where Safety Net and such come into play. Now that I think about it, I wonder if it would be worthwhile studying effect of reaching Safety Net on medication adherence, or effect of Therapeutic Group Premium on medication adherence.
Maimaris, W., Paty, J., Perel, P., Legido-Quigley, H., Balabanova, D., Nieuwlaat, R., & McKee, M. (2013). The Influence of Health Systems on Hypertension Awareness, Treatment, and Control: A Systematic Literature Review. PLoS Medicine, 10(7). Retrieved 19/08/2013 from
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001490